Scott Mace on Health Care

Short, to the point, and misleading

More trouble for an AdWords-happy and tweet-happy advertising world: Google and Yahoo Claim FDA Warning Resulted In Fuzzier Pharma Ads.

Report slams FDA oversight of studies on commercially-available drugs

As I study the drug development process, this news item from last week caught my eye:

FDA Oversight of Postmarketing Studies Slammed

"Postmarketing" is FDA-speak for all the studies of a drug's safety and effectiveness that follow the commercial release of the drug into the general patient population.